Back

Conclusion; EBAC Evaluation

10 May 2026 (15:10 - 15:15)
Organised by: Logo
Congress Presentation Part of: Beyond the class effect: exploring distinct mechanisms and clinical profiles of cardiac myosin inhibitors Hypertrophic Cardiomyopathy Open Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Martin Maron

Lahey Hospital & Medical Centre, Burlington (United States of America)

4 More presentations in this session

Presentation thumbnail
Beyond the class effect: exploring distinct mechanisms and clinical profiles of cardiac myosin inhibitors
Doctor M. Maron (Burlington, US)
Presentation thumbnail
The science and trials behind CMIs
Doctor M. Maron (Burlington, US)
Presentation thumbnail
Navigating the nuances: comparative CMI profiles
Professor C. Schulze (Jena, DE)
Presentation thumbnail
Rethinking standard of care in obstructive HCM
Doctor M. Michels (Rotterdam, NL)

Access the full session

Session thumbnail
Beyond the class effect: exploring distinct mechanisms and clinical profiles of cardiac myosin inhibitors

The Event

Event poster

Heart Failure 2026

10 May 2026 15:10 CET
You may be interested in
thumbnail
Congress Session
Risk assessment and prevention of sudden cardiac death in cardiomyopathies
thumbnail
Congress Session
Gaps in risk stratification for patients with structural heart disease
thumbnail
Webinar
The role of cardiac magnetic resonance for patients with ventricular arrhythmias and the prevention of sudden cardiac death in light of the 2022 ESC Guidelines

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources